Saturday 17 October 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024. In the quarter to June 2026, revenue grew 17.3%, EPS grew 16.2%, free cash flow grew 12.2% and total debt fell 2.77%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five.
176.63
1.48
−0.83%
Follow ENSG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
30.05 | 28.99 | 31.83 | 24.40 |
P/S ratio |
2.05 | 1.97 | 2.21 | 1.69 | |
P/FCF ratio |
34.56 | 26.93 | 28.67 | 22.17 | |
P/Operating CF |
64.80 | 54.46 | 116.23 | 54.03 | |
P/B ratio |
4.67 | 4.47 | 4.91 | 3.80 | |
Price to Tangible BV |
4.91 | 4.69 | 5.14 | 3.97 | |
EV/Sales |
1.98 | 1.89 | 2.12 | 1.66 | |
EV/EBITDA |
19.01 | 18.00 | 20.02 | 15.63 | |
EV/Operating CF |
19.84 | 16.93 | 18.89 | 14.97 | |
EV/FCF |
33.29 | 25.77 | 27.55 | 21.74 | |
Quick Ratio |
1.36 | 1.35 | 1.48 | 1.12 | |
Current Ratio |
1.46 | 1.42 | 1.56 | 1.21 | |
Net Debt/EBITDA |
(2.95) | (2.84) | (2.95) | (1.17) | |
Debt/Assets |
2.73% | 2.59% | 2.51% | 2.43% | |
Debt/Equity |
0.07 | 0.06 | 0.06 | 0.06 | |
Asset Turnover |
0.98 | 1.00 | 1.02 | 1.03 | |
Operating CF/Net income |
1.82 | 1.92 | 1.00 | 1.72 | |
Capex/Depreciation |
(1.90) | (1.79) | (1.22) | (1.67) | |
Interest Coverage |
48.82 | 63.33 | 64.62 | 63.38 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.20% | 5.20% | 5.34% | 5.96% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
1.00% | 0.95% | 1.00% | 1.12% | |
Graham Net Nets |
(0.19) | (0.20) | (0.17) | (0.24) | |
Graham Number |
69.18 | 72.62 | 76.43 | 78.97 | |
Earnings Yield |
3.33% | 3.45% | 3.14% | 4.10% | |
Free Cash Flow Yield |
2.89% | 3.71% | 3.49% | 4.51% | |
Revenue per Share |
22.59 | 23.74 | 24.05 | 24.85 | |
Operating CF per Share |
2.67 | 3.20 | 1.73 | 2.97 | |
Capex per Share |
(0.89) | (0.87) | (0.61) | (0.91) | |
Free Cash Flow per Share |
1.78 | 2.33 | 1.12 | 2.06 | |
Cash per Share |
8.82 | 9.99 | 10.30 | 5.54 | |
Shareholders Equity per Share |
37.00 | 39.00 | 41.02 | 42.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.00 | 39.00 | 41.02 | 42.19 | |
Free Cash Flow |
101.93 | 133.35 | 64.68 | 119.13 | |
Working Capital |
381.35 | 377.96 | 472.05 | 186.69 | |
Capital Expenditures |
(51.07) | (49.97) | (35.47) | (52.83) | |
Net Current Asset Value |
(1,896.96) | (1,955.84) | (1,921.96) | (2,232.60) | |
EV/EBIT |
23.74 | 22.46 | 24.93 | 19.49 | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.04 | |
Price to Operating Income |
24.64 | 23.47 | 25.94 | 19.88 | |
| Other line items | |||||
Average Receivables |
583.42 | 603.44 | 623.65 | 623.48 | |
Average Payables |
98.04 | 98.14 | 105.73 | 111.24 | |
Average Assets |
4,927.80 | 5,066.16 | 5,185.80 | 5,339.84 | |
Average Common Equity |
1,936.92 | 2,037.63 | 2,149.93 | 2,233.15 |
Columns are period end dates